H -- LABORATORY TESTING SERVICES

Notice Date

September 5, 2001

Contracting Office

Acquisitions Management Operations Branch, NIAID, 6700-B Rockledge Drive, Room 1130, Bethesda, MD 20892-7605

ZIP Code

20892-7605

Solicitation Number

NOI1013

Response Due

September 21, 2001

Point of Contact

Sylvia Robinson, Purchasing Agent (301) 496-2814/Carolyn Sentz, Contracting Officer (301) 402-2282

Description

17. This is a combined synopsis/notice of intent to procure commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are not being requested and a written solicitation will not be issued. The solicitations number for this acquisition is NOI1013 and is being issued as a notice of intent. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular 97-27. This acquisition will be processed under Simplified Acquisition Procedures (SAP) and is not a small business set-aside The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the small business size is 500. The National Institute of Allergy and Infectious Diseases intends to procure testing services with the University of Maryland Greenbaum Cancer Center for non-human primates as part of a pre-clinical research of hematopoietic stem cell gene therapy. This service will be used to test some important methods of the gene transfer program, which is a critical phase of patient studies. This service/work relates to research collaboration with the University of Maryland Greenbaum Cancer Center for development of gene therapy for immune disorders. This achievement can only be obtained from blood cells delivered from treated animals from the same facility as previous and on-going studies. Dr. Thomas MacVitte of the University of Maryland Greenbaum Cancer Center has the specialized expertise in the harvest of mobilized peripheral blood stem cells from rhesus monkeys using apheresis and bone marrow transplantation in rhesus monkeys. The contractor is to provide all the necessary services, qualified personnel, materials, equipment, facilities, animals, quarantine housing, study housing to perform specialized testing including administration of hematopoietic growth factors, peripheral blood apheresis, administration of chemotherapeutic agents or total body irradiation, bone marrow aspiration, performance of post-mortem examinations, collection and transfusion of blood products or gene-transduced stem cells and arrange for transport of cell products from their facility to the Clinical Center of the NIH. The contractor is to be AAALAC accredited. The following FAR provisions and clauses apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items; FAR 52.212.3 Offeror Representations and Certifications Commercial Items; FAR 52.212-4 Contractor Terms and Conditions Commercial Items; FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items. Offerors must include with their offer a completed copy of provisions at FAR 52.212-3 Offerors Representations and Certifications Commercial Items. Copies of the aforementioned clauses are available upon request by telephone to Ms. Sylvia Robinson at (301) 496-2814. For delivery through the Postal Service, the address is NIH/NIAID/AMOB, 6700B Rockledge Drive/MSC7605, Room 1130; Bethesda, Maryland 20817-7605. Electronic submission will not be accepted. Requests for information concerning this requirement are to be addressed to Ms. Sylvia Robinson at (301) 496-2814. Collect calls will not be accepted.

Record

Loren Data Corp. 20010907/HSOL001.HTM (W-248 SN50W8O4)